<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1236705</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Quorum-sensing in Gram-positive pathogens &#x2013; mechanisms, role in infection, and potential as a therapeutic target</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Otto</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/94613"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dickey</surname>
<given-names>Seth W.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1801966"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wolz</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/47747"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Veterinary Medicine, University of Maryland, College Park</institution>, <addr-line>MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Virginia-Maryland College of Veterinary Medicine, College Park</institution>, <addr-line>MD</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Interfaculty Institute of Microbiology and Infection Medicine, University of T&#xfc;bingen</institution>, <addr-line>T&#xfc;bingen</addr-line>, <country>Germany</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Cluster of Excellence EXC 2124 &#x201c;Controlling Microbes to Fight Infections&#x201d;, University of T&#xfc;bingen</institution>, <addr-line>T&#xfc;bingen</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Alain Filloux, Imperial College London, United Kingdom</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Michael Otto, <email xlink:href="mailto:motto@niaid.nih.gov">motto@niaid.nih.gov</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1236705</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Otto, Dickey and Wolz</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Otto, Dickey and Wolz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/34897" ext-link-type="uri">Editorial on the Research Topic <article-title>Quorum-sensing in Gram-positive pathogens &#x2013; mechanisms, role in infection, and potential as a therapeutic target</article-title>
</related-article>
<kwd-group>
<kwd>quorum-sensing (QS)</kwd>
<kwd>staphylococcus</kwd>
<kwd>streptococcus</kwd>
<kwd>AGR</kwd>
<kwd>infection</kwd>
<kwd>antivirulence</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="15"/>
<page-count count="3"/>
<word-count count="988"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>The term &#x201c;quorum-sensing&#x201d; (QS) describes a mechanism by which bacteria sense the density of the population and adjust gene expression accordingly. This mechanism allows the bacteria to adapt their physiology to the change in environmental conditions that accompanies the growth of the population, most notably a scarcity of nutrients (<xref ref-type="bibr" rid="B9">Miller and Bassler, 2001</xref>). During infection, the responsibility of QS control is believed to postpone the production of &#x201c;public goods&#x201d; until the bacteria have grown to growth-limiting densities, at which point the QS-controlled products can be produced at sufficient concentrations. Many of the QS-controlled factors are toxins and immune-modulatory molecules which for example control infiltrating immune cells (<xref ref-type="bibr" rid="B7">Le and Otto, 2015</xref>). At high density, the bacteria can also afford to produce QS-controlled degradative exoenzymes to acquire nutrients or essential ions from the host tissue.</p>
<p>QS is generally based on the secretion of a signal molecule, sometimes called pheromone or autoinducer (AI), which controls its own biosynthesis in a positive feedback loop and upon reaching a certain extracellular threshold concentration triggers a signal cascade that ultimately leads to the changes in the expression of QS-controlled genes (the QS regulon) (<xref ref-type="bibr" rid="B9">Miller and Bassler, 2001</xref>). Because accumulation of the signal requires a closed system and a threshold can also be reached with a relatively low number of bacteria in a small system with limited diffusion, QS has also been called &#x201c;diffusion sensing&#x201d; (<xref ref-type="bibr" rid="B13">Redfield, 2002</xref>).</p>
<p>QS in Gram-negative and Gram-positive bacteria generally follows the same general principle. However, in Gram-negative bacteria the QS systems use small, membrane-diffusible signal molecules, whereas Gram-positive bacteria use non-membrane diffusible peptide-based signals, sometimes called autoinducing peptides (AIPs) (<xref ref-type="bibr" rid="B8">Lyon and Novick, 2004</xref>). AIPs require dedicated export systems and membrane-located sensing systems or, in some cases, dedicated importers together with intracellular sensors. Membrane-located sensors commonly belong to the family of so-called two-component systems, which comprise a signal-binding membrane-spanning histidine kinase enzyme and a cognate cytoplasmic response regulator to which activation is transferred <italic>via</italic> phosphorylation (<xref ref-type="bibr" rid="B9">Miller and Bassler, 2001</xref>; <xref ref-type="bibr" rid="B8">Lyon and Novick, 2004</xref>).</p>
<p>Much of the considerable interest in QS stems from the fact that it controls virulence mechanisms and is thus a premier target for antivirulence drug development approaches (<xref ref-type="bibr" rid="B2">Dickey et&#xa0;al., 2017</xref>). Among QS systems of Gram-positive bacteria, the Agr system of <italic>Staphylococcus aureus</italic> has been most studied in terms of mechanism, control of virulence, and exploitation as an antivirulence target. The interesting phenomenon of species/subgroup-specific AIP variation and cross-inhibition that is present in this genus is being exploited as a basis for QS-targeted antivirulence approaches (<xref ref-type="bibr" rid="B7">Le and Otto, 2015</xref>).</p>
<p>Two papers in this series address QS-controlled virulence. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2022.925914">Kinney et&#xa0;al.</ext-link> studied <italic>S. aureus</italic>-induced endocarditis by investigating in a rabbit model of endocarditis how the temporal expression of several global regulators of <italic>S. aureus</italic>, including Agr, correlates with signs of infection. They found that low expression of SarA and Agr is associated with vegetation formation as a hallmark of infective endocarditis. This is reminiscent of the notion of increased infectivity of <italic>agr</italic> mutants in other biofilm-associated infections such as prosthetic joint infection, cystic fibrosis, or device-associated bacteremia (<xref ref-type="bibr" rid="B3">Fowler et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B4">Goerke and Wolz, 2010</xref>; <xref ref-type="bibr" rid="B5">He et&#xa0;al., 2022</xref>).</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2022.801232">Wang et&#xa0;al.</ext-link> focused on sepsis and found that the host response to Gram-negative and Gram-positive bacteria can vary considerably. These findings are in line with the recently developing idea that species-specific bacterial virulence factors, including those controlled by <italic>S. aureus</italic> Agr, have a key role in determining the outcome of sepsis (<xref ref-type="bibr" rid="B1">Cheung et&#xa0;al., 2021</xref>).</p>
<p>Recent findings also indicate Agr plays a key role for staphylococcal colonization and bacterial competition during colonization, which may be exploited for decolonization strategies (<xref ref-type="bibr" rid="B12">Piewngam et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B10">Nakamura et&#xa0;al., 2020</xref>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcimb.2023.1178650">Tamai et&#xa0;al.</ext-link> in their review discuss Agr with a focus on its role in skin colonization and atopic dermatitis as well as a target for antivirulence drug development, a subject which has recently been pointed out requires more dedication, particularly using <italic>in-vivo</italic> infection models (<xref ref-type="bibr" rid="B11">Otto, 2023</xref>).</p>
<p>Some other Gram-positive bacteria also use Agr homologues (e.g., <italic>Clostridioides difficile</italic>, <italic>Enterococcus faecalis</italic>) but in these organisms, Agr control is not yet completely understood.</p>
<p>Most Gram-positive bacteria use QS systems that are not phylogenetically related to Agr, but they always also use peptide signals. Some Gram-positive bacteria have several QS systems, some of which may have very specific tasks in controlling a small and defined set of target genes. For example, group A streptococci control virulence, biofilm formation, and competence <italic>via</italic> the QS system Rgg, invasion-related genes by the <italic>sil</italic> locus, and synthesis of specific lantibiotic bacteriocins by yet further QS-like systems (<xref ref-type="bibr" rid="B6">Jimenez and Federle, 2014</xref>).</p>
<p>In addition to genus- or species-specific systems, there is a system called LuxS/AI-2 that has first been described in some Gram-negative bacteria and has been claimed to be &#x201c;universal&#x201d; (<xref ref-type="bibr" rid="B15">Schauder et&#xa0;al., 2001</xref>). AI-2 is a byproduct of the activated methyl cycle, a part of a housekeeping metabolism pathway that is conserved in bacteria. Whether it has a QS function in Gram-positive bacteria, or other bacteria in which no apparent AI-2 sensor is present, is controversial (<xref ref-type="bibr" rid="B14">Rezzonico and Duffy, 2008</xref>). <uri xlink:href="https://doi.org/10.3389/fcimb.2023.1177857">Agnew et&#xa0;al</uri>. in their contribution provide evidence for a role of interaction between LuxS and a type 1 restriction-modification system in <italic>Streptococcus pneumoniae</italic>, which the authors&#x2019; results suggest may play a role in infection and niche adaptation.</p>
<p>While QS is a large field with many important studies being published almost constantly, we still hope that the studies published in this series will give readers some valuable additional insight especially given that QS in Gram-positive bacteria remains understudied in comparison.</p>
<sec id="s1" sec-type="author-contributions">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
</body>
<back>
<sec id="s2" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (to MO, project number ZIA AI000904), University of Maryland (to SD, startup funds) and by infrastructural funding from the Deutsche Forschungsgemeinschaft (DFG), Cluster of Excellence EXC 2124 &#x201c;Controlling Microbes to Fight Infections&#x201d; (to CW, Project 390838134).</p>
</sec>
<sec id="s3" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s4" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheung</surname> <given-names>G. Y. C.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hunt</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Otto</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Bacterial virulence plays a crucial role in MRSA sepsis</article-title>. <source>PloS Pathog.</source> <volume>17</volume>, <fpage>e1009369</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1009369</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickey</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>G. Y. C.</given-names>
</name>
<name>
<surname>Otto</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance</article-title>. <source>Nat. Rev. Drug Discovery</source> <volume>16</volume>, <fpage>457</fpage>&#x2013;<lpage>471</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrd.2017.23</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fowler</surname> <given-names>V. G.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Sakoulas</surname> <given-names>G.</given-names>
</name>
<name>
<surname>McIntyre</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Meka</surname> <given-names>V. G.</given-names>
</name>
<name>
<surname>Arbeit</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Cabell</surname> <given-names>C. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Persistent bacteremia due to methicillin-resistant <italic>Staphylococcus aureus</italic> infection is associated with agr dysfunction and low-level <italic>in vitro</italic> resistance to thrombin-induced platelet microbicidal protein</article-title>. <source>J. Infect. Dis.</source> <volume>190</volume>, <fpage>1140</fpage>&#x2013;<lpage>1149</lpage>. doi: <pub-id pub-id-type="doi">10.1086/423145</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goerke</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wolz</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Adaptation of <italic>Staphylococcus aureus</italic> to the cystic fibrosis lung</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>300</volume>, <fpage>520</fpage>&#x2013;<lpage>525</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijmm.2010.08.003</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Jian</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hamushan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Key role of quorum-sensing mutations in the development of <italic>Staphylococcus aureus</italic> clinical device-associated infection</article-title>. <source>Clin. Transl. Med.</source> <volume>12</volume>, <fpage>e801</fpage>. doi: <pub-id pub-id-type="doi">10.1002/ctm2.801</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jimenez</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Federle</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Quorum sensing in group a streptococcus</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>4</volume>, <elocation-id>127</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2014.00127</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le</surname> <given-names>K. Y.</given-names>
</name>
<name>
<surname>Otto</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Quorum-sensing regulation in staphylococci-an overview</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>, <elocation-id>1174</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2015.01174</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyon</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Novick</surname> <given-names>R. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Peptide signaling in <italic>Staphylococcus aureus</italic> and other gram-positive bacteria</article-title>. <source>Peptides</source> <volume>25</volume>, <fpage>1389</fpage>&#x2013;<lpage>1403</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.peptides.2003.11.026</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Bassler</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Quorum sensing in bacteria</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>55</volume>, <fpage>165</fpage>&#x2013;<lpage>199</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.micro.55.1.165</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Takaya</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Katayama</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kusuya</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>
<italic>Staphylococcus</italic> agr virulence is critical for epidermal colonization and associates with atopic dermatitis development</article-title>. <source>Sci. Transl. Med.</source> <volume>12</volume>. doi: 10.1126/scitranslmed.aay4068</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otto</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Critical assessment of the prospects of quorum-quenching therapy for <italic>Staphylococcus aureus</italic> infection</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>. doi: <pub-id pub-id-type="doi">10.3390/ijms24044025</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piewngam</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>T. H.</given-names>
</name>
<name>
<surname>Dickey</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Joo</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Villaruz</surname> <given-names>A. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Pathogen elimination by probiotic <italic>Bacillus via</italic> signalling interference</article-title>. <source>Nature</source> <volume>562</volume>, <fpage>532</fpage>&#x2013;<lpage>537</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-018-0616-y</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redfield</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Is quorum sensing a side effect of diffusion sensing</article-title>? <source>Trends Microbiol.</source> <volume>10</volume>, <fpage>365</fpage>&#x2013;<lpage>370</lpage>. doi: 10.1016/s0966-842x(02)02400-9</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezzonico</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Duffy</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Lack of genomic evidence of AI-2 receptors suggests a non-quorum sensing role for <italic>luxS</italic> in most bacteria</article-title>. <source>BMC Microbiol.</source> <volume>8</volume>, <fpage>154</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2180-8-154</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schauder</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shokat</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Surette</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Bassler</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The LuxS family of bacterial autoinducers: biosynthesis of a novel quorum-sensing signal molecule</article-title>. <source>Mol. Microbiol.</source> <volume>41</volume>, <fpage>463</fpage>&#x2013;<lpage>476</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02532.x</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>